| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/19/2006 | WO2005085838A3 Computational analysis of mass spectroscopic lipid data |
| 01/19/2006 | WO2005085412A3 Method and device for the measurement and characterisation of a biomass, application thereof in relation to on-line biomass data measuring in a fermentation process and associated control method |
| 01/19/2006 | WO2005074609A3 Test strip composition and method to measure cholesterol from low density lipoproteins |
| 01/19/2006 | WO2005073732A3 Lc/ms method of analyzing high molecular weight proteins |
| 01/19/2006 | WO2005056576A3 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/19/2006 | WO2005046452A3 A polypeptide complex that regulates cell cycle and anergy |
| 01/19/2006 | WO2005045392A3 Detection and identification of biopolymers using fluorescence quenching |
| 01/19/2006 | WO2005038005A3 Shc proteins as therapeutic targets in proliferative diseases |
| 01/19/2006 | WO2005015238A3 Platinum complexes for differential mass labelling |
| 01/19/2006 | WO2004096841A8 Glut-1 as a receptor for htlv envelopes and its uses |
| 01/19/2006 | US20060015952 Screening assays and methods of tumor treatment |
| 01/19/2006 | US20060015948 Zebrafish assay |
| 01/19/2006 | US20060015264 Interfering stem-loop sequences and method for identifying |
| 01/19/2006 | US20060015262 Method and system for automated quantitation of tissue micro-array (TMA) digital image analysis |
| 01/19/2006 | US20060015261 Blood clotting predictor |
| 01/19/2006 | US20060014936 Hybrid bacillus thuringiensis Cry1A/Cry1F DNA and plants and host cells transformed with same |
| 01/19/2006 | US20060014934 Crystal structure of factor Vai and method for identifying blood factor Va modulators |
| 01/19/2006 | US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 01/19/2006 | US20060014799 of isomeric ratios omeprazole mixtures |
| 01/19/2006 | US20060014746 Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 01/19/2006 | US20060014735 immunoglobulins; affinity chromatography |
| 01/19/2006 | US20060014727 Angiogenic compounds and uses thereof |
| 01/19/2006 | US20060014688 Methods of inhibiting tumor cell proliferation |
| 01/19/2006 | US20060014687 Bone delivery conjugates and method of using same to target proteins to bone |
| 01/19/2006 | US20060014686 Screening for agents that modulate the activity or expression of FOXM1; determining whether a subject has lung, colon, or breast cancer |
| 01/19/2006 | US20060014672 Tumor specific oligosaccharide epitopes and use thereof |
| 01/19/2006 | US20060014315 Stable, water-soluble quantum dot, method of preparation and conjugates thereof |
| 01/19/2006 | US20060014302 Point of care diagnostic systems |
| 01/19/2006 | US20060014301 Antibody-based system for detection of differential protein expression patterns |
| 01/19/2006 | US20060014300 Sensor for detection and identification of biological particles |
| 01/19/2006 | US20060014298 Method and kitset for sampling and storage of biological samplies |
| 01/19/2006 | US20060014297 Clinical method for the genetic screening of newborns using tandem mass spectrometry |
| 01/19/2006 | US20060014294 Serum marker for measuring liver fibrosis |
| 01/19/2006 | US20060014293 Lock mass ions for use with derivatized peptides for de novo sequencing using tandem mass spectrometry |
| 01/19/2006 | US20060014251 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-II subunit (CACNA1I) |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014238 Method and system for automated detection of immunohistochemical (IHC) patterns |
| 01/19/2006 | US20060014235 in vitro method for quantifying exposure to psychological stress which relies on measuring the retained ability of neutrophils, preferably neutrophils in a whole blood sample, to exhibit challenge-induced superoxide anion production; drug screening |
| 01/19/2006 | US20060014234 Protected phosphorylated proteins or peptides are captured by reaction with a diazo moiety linked to a separation medium, isolated from the non-phosphorylated components of the mixture, released from the separation medium, and subsequently characterized by physicochemical means |
| 01/19/2006 | US20060014232 Immobilization method |
| 01/19/2006 | US20060014229 reacting sample with cholesterol esterase and cholesterol oxidase or oxidized coenzyme and cholesterol dehydrogenase in aqueous medium comprising nonionic surfactant, dextran sulfate and albumin, and measuring formed hydrogen peroxide |
| 01/19/2006 | US20060014228 Monolithic biosensors containing a bioluminescent microorganism which harbors a lux gene fused with a heterologous promoter gene stably incorporated into a chromosome; Optical Application Specific Integrated Circuit |
| 01/19/2006 | US20060014227 Methods, compositions, and kits for the detection of bacteria in a sample |
| 01/19/2006 | US20060014226 Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans infection |
| 01/19/2006 | US20060014225 Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 01/19/2006 | US20060014224 Method for detecting, screening and/or monitoring a cancer in an individual |
| 01/19/2006 | US20060014223 Method for diagnosing cancer by detecting gpc3 |
| 01/19/2006 | US20060014222 Antibodies |
| 01/19/2006 | US20060014221 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma |
| 01/19/2006 | US20060014220 Multipurpose linker compounds and ligands and process for producing the same |
| 01/19/2006 | US20060014219 Method for measuring ion channel activity |
| 01/19/2006 | US20060014218 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) |
| 01/19/2006 | US20060014217 Sphingomyelin detecting probe |
| 01/19/2006 | US20060014216 Prophylaxis, therapy of Alzheimer's disease; using phenothiazine compound such as methylene blue |
| 01/19/2006 | US20060014215 Process for detecting PRPsc using an antibiotic from the family of aminoglycosides |
| 01/19/2006 | US20060014214 Urine preservation system |
| 01/19/2006 | US20060014213 Diagnosing diseases involving altered neuropathology, including methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies; methods utilize visualization techniques such as optical coherence tomography |
| 01/19/2006 | US20060014212 Proteome epitope tags and methods of use thereof in protein modification analysis |
| 01/19/2006 | US20060014211 Detection of mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of the peritoneum and the peritoneal cavity |
| 01/19/2006 | US20060014210 Reacting with 2-methoxy-4,5-dihydro-1H-imidazole; determining amino acid sequence; improved data quality |
| 01/19/2006 | US20060014209 Determining the level of ubiquitin, the level of A beta 1-42, and the level of tau present in a sample of cerebrospinal fluid, especially by competitive ELISA using a monoclonal antibody which recognizes the amino acid residues 64-76 of ubiquitin |
| 01/19/2006 | US20060014208 Functional assays for identifying compounds that modulate T1R2/T1R3 (sweet) taste |
| 01/19/2006 | US20060014207 Method of measuring lipid in specific lipoprotein |
| 01/19/2006 | US20060014206 Assay methods for state-dependent calcium channel agonists/antagonists |
| 01/19/2006 | US20060014203 carbon nanotubes as electrodes; for biopolymers such as DNA and RNA |
| 01/19/2006 | US20060014202 production method of electrical connection structure and electric wiring; carbon nanotube as the electrode and contacting the electrode with the biopolymer (DNA, RNA, or a protein) then applying an electric current between the electrode and biopolymer |
| 01/19/2006 | US20060014201 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 01/19/2006 | US20060014200 Apparatus for analysis of a nucleic acid amplification reaction |
| 01/19/2006 | US20060014198 Method for apparatus for detecting luminescence light from a porous support structure |
| 01/19/2006 | US20060014184 Contacting a compound with a polypeptide having a specific amino acid sequence and measuring a compound-polypeptide property related to extra-cellular matrix (ECM) degradation, e.g., activation of a biological pathway producing a biochemical marker indicative of ECM degradation such as MMP1 |
| 01/19/2006 | US20060014182 Using hybrid RNA/DNA primer to replicate/propagate preferential messengegr RNA polynucleotides; gene expression analysis and drug discovery |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060014177 A sample storage substrate comprising an elastomeric substrate made of open cell foam, closed cell foam, or a combination thereof and a biological sample absorbed by the elastomeric substrate; resists degradation |
| 01/19/2006 | US20060014176 Reactor for chemical synthesis |
| 01/19/2006 | US20060014172 Aptamer-nanoparticle conjugates and method of use for target analyte detection |
| 01/19/2006 | US20060014162 As a target for drug development against Chagas' disease |
| 01/19/2006 | US20060014161 Combination comprising biochip and optical detection device |
| 01/19/2006 | US20060014160 Determining whether or not mammary gland sodium/iodide symporter (mgNIS) is expressed in breast tissue of the subject, whereinexpression of mgNIS in the breast tissue is detected using an antibody, specific for mgNIS, expression of mgNIS in the breast tissue of is indicative of breast cancer presence |
| 01/19/2006 | US20060014158 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 01/19/2006 | US20060014157 Sensitivity test to predict efficacy of anti-cancer therapies |
| 01/19/2006 | US20060014156 Nucleic acid detecting or quantifying processes |
| 01/19/2006 | US20060014151 Optical dna sensor, dna reading apparatus, identification method of dna and manufacturing method of optical dna sensor |
| 01/19/2006 | US20060014148 Igg fc/hiv-gp120/c3d fusion protien |
| 01/19/2006 | US20060014147 Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) |
| 01/19/2006 | US20060014145 Methods and articles for high throughput analysis of biomolecular interactions |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060014138 detecting the presence or absence of a humoral response to a tumor antigen selected from Eukaryotic Translation Initiation Factor 4Gamma 1 (eIF4G 1), Ribosomal Protein L22 (RPL22), Ribosomal Protein L 13A (RPL13A), and protein XP-373908; prostate cancer |
| 01/19/2006 | US20060014135 Assay for distinguishing live and dead cells |
| 01/19/2006 | US20060013831 adjuvant peptide and heterologous an antigen; human immunodeficiency virus (HIV)-related peptides; antigen is cholera toxin; fusion protein |
| 01/19/2006 | US20060013817 identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which said genetic products that are expressed in association with a tumor are expressed in an aberrant manner. |
| 01/19/2006 | US20060013815 Human Mob-5 (IL-24) receptors and uses thereof |
| 01/19/2006 | US20060013813 Proteins and nucleic acids encoding same |
| 01/19/2006 | US20060013804 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 01/19/2006 | US20060013802 Pumping device equipped with catheter; directly delivering interleukin 10 signal transduction modifying agent to cerebrospinal fluid and/or brain tissue |
| 01/19/2006 | US20060013770 Method for screening for compounds as potential sedatives or anxiolytics |
| 01/19/2006 | US20060013740 Apparatus comprising cell counting station, pressure actuating component and conduit connecting cell to counting station; erythrocyte analysis; a disposable apparatus for use in blood testing allowing simultaneous dilution of a blood sample to two defined dilutions ratios |
| 01/19/2006 | US20060013732 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 01/19/2006 | US20060013731 Microfluidic system with feedback control |
| 01/19/2006 | US20060013729 Fluid handling apparatus for an automated analyzer |